It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Oxidized phospholipids (oxPAPC) induce endothelial dysfunction and atherosclerosis. Here we show that oxPAPC induce a gene network regulating serine-glycine metabolism with the mitochondrial methylenetetrahydrofolate dehydrogenase/cyclohydrolase (MTHFD2) as a causal regulator using integrative network modeling and Bayesian network analysis in human aortic endothelial cells. The cluster is activated in human plaque material and by atherogenic lipoproteins isolated from plasma of patients with coronary artery disease (CAD). Single nucleotide polymorphisms (SNPs) within the MTHFD2-controlled cluster associate with CAD. The MTHFD2-controlled cluster redirects metabolism to glycine synthesis to replenish purine nucleotides. Since endothelial cells secrete purines in response to oxPAPC, the MTHFD2-controlled response maintains endothelial ATP. Accordingly, MTHFD2-dependent glycine synthesis is a prerequisite for angiogenesis. Thus, we propose that endothelial cells undergo MTHFD2-mediated reprogramming toward serine-glycine and mitochondrial one-carbon metabolism to compensate for the loss of ATP in response to oxPAPC during atherosclerosis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Bibli, Sofia Iris 4 ; Li, Xiaogang 5 ; Zukunft, Sven 4
; Pflüger, Beatrice 1 ; Hu, Jiong 4 ; Schürmann, Christoph 1 ; Vasconez, Andrea Estefania 1 ; Oo, James A 1 ; Kratzer, Adelheid 6 ; Kumar, Sandeep 7
; Rezende, Flávia 1 ; Josipovic, Ivana 1 ; Thomas, Dominique 8 ; Giral, Hector 6 ; Schreiber, Yannick 9 ; Geisslinger, Gerd 10 ; Fork, Christian 1 ; Yang, Xia 11 ; Sigala, Fragiska 12 ; Romanoski, Casey E 13 ; Kroll, Jens 5 ; Hanjoong Jo 7
; Landmesser, Ulf 14 ; Lusis, Aldons J 15 ; Namgaladze, Dmitry 16 ; Fleming, Ingrid 4 ; Leisegang, Matthias S 1 ; Zhu, Jun 2
; Brandes, Ralf P 1 1 Institute for Cardiovascular Physiology, Goethe University, Frankfurt am Main, Germany; German Center for Cardiovascular Research (DZHK) (Partner site Rhine-Main), Frankfurt am Main, Germany
2 Icahn Institute of Genomics and Multiscale Biology, Mount Sinai Icahn School of Medicine, New York, NY, USA; Sema4 Genomics (a Mount Sinai venture), Stamford, CT, USA
3 Icahn Institute of Genomics and Multiscale Biology, Mount Sinai Icahn School of Medicine, New York, NY, USA; Department of Mathematics, Hebei University of Science and Technology, Shijiazhuang, Hebei, China
4 German Center for Cardiovascular Research (DZHK) (Partner site Rhine-Main), Frankfurt am Main, Germany; Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, Germany
5 Department of Vascular Biology and Tumor Angiogenesis, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
6 Department of Cardiology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany; German Center for Cardiovascular Research (DZHK) (Partner site Berlin), Berlin, Germany
7 Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA
8 Institute of Clinical Pharmacology, Pharmazentrum Frankfurt/ZAFES, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany
9 Fraunhofer Institute of Molecular Biology and Applied Ecology—Project Group Translational Medicine and Pharmacology (IME-TMP), Frankfurt am Main, Germany
10 Institute of Clinical Pharmacology, Pharmazentrum Frankfurt/ZAFES, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany; Fraunhofer Institute of Molecular Biology and Applied Ecology—Project Group Translational Medicine and Pharmacology (IME-TMP), Frankfurt am Main, Germany
11 Department of Integrative Biology and Physiology, University of California, Los Angeles, CA, USA
12 1st Department of Propaedeutic Surgery, University of Athens Medical School, Hippocration Hospital, Athens, Greece
13 Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, USA
14 Department of Cardiology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany; German Center for Cardiovascular Research (DZHK) (Partner site Berlin), Berlin, Germany; Berlin Institute of Health (BIH), Berlin, Germany
15 Departments of Medicine, Microbiology and Human Genetics, University of California, Los Angeles, CA, USA
16 Institute of Biochemistry I, Goethe University, Frankfurt am Main, Germany




